Tolfine

Product Description

INDICATIONS
In cattle:
Reduction of inflammation associated with musculoskeletal and respiratory infections

CONTRAINDICATIONS
The use of this veterinary medicine is not recommended in the case of heart, liver or kidney failure.
Tolfenamic acid is contraindicated in the case of ulcerations or digestive bleeding.
Do not use in case of hypersensitivity to the active substances or to any of the excipients.

Suitable for:

Brand:

Tolfine-Img

Characteristics

ADVERSE REACTIONS
A transient inflammation and tumefaction may appear at the injection site. If you notice any serious effects or other effects not mentioned in this package leaflet, please inform your veterinary surgeon

TARGET SPECIES
Cattle

WITHDRAWAL PERIOD
Intramuscular route:
Meat and offal: 12 days. Milk: zero day
Intravenous route:
Meat and offal: 4 days. Milk: 12 hours

SPECIAL STORAGE PRECAUTIONS
After opening: 28 days.
Protect from light.
Keep out of the sight and reach of children.
Do not store above 25°C.

SPECIAL WARNINGS
Special warnings for each target species
Do not inject more than 20 ml per injection site.
Special precautions for use in animals
Use aseptic precautions when administering the product.
Do not use in dehydrated, hypovolaemic or hypotensive animals
(potential risk of increased renal toxicity).
The concurrent administration of potentially nephrotoxic drugs must be
avoided
Special precautions to be taken by the person administering the medicinal product to animals
In case of contact with the skin or eyes, immediately rinse with water
Use during pregnancy or lactation
The safety of the product has not been established during pregnancy
Use only accordingly to the benefit/risk assessment by the responsible veterinarian.
Interaction with other medicinal products and other forms of interaction
Do not administer other non-steroidal anti-inflammatories concurrently or within 24 hours of each other. Tolfenamic acid is strongly bound to plasma proteins and may compete with other strongly bound drugs

Overdose
At high doses, transient neurological disorders have been observed in cows.

SPECIAL PRECAUTIONS FOR THE DISPOSAL OF UNUSED VETERINARY MEDICINAL PRODUCT OR WASTE MATERIALS DERIVED FROM THE USE OF SUCH PRODUCTS
Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local regulations.

PRESENTATIONS
10 ml vial, 25 ml vial, 30 ml vial, 50 ml vial, 100 ml vial, 250 ml vial

FOR ANIMAL TREATMENT ONLY
TO BE SUPPLIED ONLY ON VETERINARY PRESCRIPTION

Composition

. .

Dosage and Instructions

2 mg per kg bodyweight, i.e. 1 ml per 20 kg bodyweight, by intramuscular injection, to be repeated every 48 hours.
2 mg per kg bodyweight, i.e. 1 ml per 20 kg bodyweight, by intravenous injection, to be repeated every 24 hours, or to be relayed 24 hours later with intramuscular injections.
Do not exceed 5 consecutive injections

Cow

Cow

Intramuscular injection: one injection of 1 ml per 20 kg of body weight and repeated every 48 hours.
Intravenous injection: One injection of 1 ml per 20 kg body weight and repeated every 24 hours or 24 hours after intramuscular injection.
The number of injections should not be more than 5 consecutive times.

calf

Calf

Horse

Horse

Intramuscular and intraperitoneal injection.
20-25 ml

foal

Foal

Intramuscular and intraperitoneal injection.
10-15 ml

sheep

sheep

Intramuscular, subcutaneous and oral
Adult: 5 ml - Young: 1-2 ml

chiken

Hen

chiken

Chicken

Cat

Cat

dog

Dog

fish

Fish